Bridgewealth Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Buy
2,453
+121
+5% +$28.2K 0.12% 71
2026
Q1
$570K Buy
2,332
+11
+0.5% +$2.56K 0.12% 74
2025
Q4
$480K Buy
2,321
+107
+5% +$21.2K 0.11% 79
2025
Q3
$410K Buy
2,214
+8
+0.4% +$1.37K 0.1% 77
2025
Q2
$337K Buy
+2,206
New +$339K 0.09% 82
2025
Q1
Sell
-2,466
Closed -$388K 76
2024
Q4
$388K Buy
2,466
+874
+55% +$135K 0.11% 68
2024
Q3
$258K Buy
+1,592
New +$254K 0.09% 68

Other funds holding JNJ

Bridgewealth Advisory Group's JNJ Position: Q2 2026 in Review

Bridgewealth Advisory Group increased its Johnson & Johnson (JNJ) stake by 5.2% in Q2 2026, buying an estimated $28.2K and bringing the position to 2,453 shares worth $623K. The position accounts for 0.12% of the portfolio, ranked #71.

Bridgewealth Advisory Group first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bridgewealth Advisory Group held 2,453 shares of Johnson & Johnson worth $623K as of Q2 2026.
  • Bridgewealth Advisory Group bought 121 Johnson & Johnson shares in Q2 2026, an estimated $28.2K.
  • Johnson & Johnson made up 0.12% of Bridgewealth Advisory Group's portfolio in Q2 2026, its #71 holding.
  • Bridgewealth Advisory Group first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bridgewealth Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.